LGND May 2024 80.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:20PM EDT. Market open.
Loading interactive chart…
- Zacks
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
- Zacks
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Amgen's (AMGN) Imdelltra is the first DLL3-targeting BiTE therapy that activates the patient's own T cells to attack DLL3-expressing tumor cells.
- Zacks
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Ionis (IONS) and Biogen (BIIB) stop developing their experimental ALS drug after a phase I/II study failed to show improvement in patients.
© 2024 Yahoo. All rights reserved.